Skip to content

RNTX RNTX Accounts Payable

Accounts Payable at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$4.23B+5.8%
Gilead Sciences logo
Gilead SciencesGILD
$645M-12.5%
CTO
Citius Oncology, Inc.CTOR
$8.88M+15.7%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
$2.76M+79.9%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$265K+117%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$10.84M+7.9%

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+164%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Reported directly by RNTX in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's accounts payable?
RNTX (RNTX) reported accounts payable of $6.26M in Q1 2026.
How has RNTX's accounts payable changed year-over-year?
RNTX's accounts payable increased by 445.1% year-over-year, from $1.15M to $6.26M.
What is the long-term trend for RNTX's accounts payable?
Over 5 years (2020 to 2025), RNTX's accounts payable has grown at a 20.0% compound annual growth rate (CAGR), from $1.6M to $3.98M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.